Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-11C]-2-(4-methylaminophenyl)- 6-hydroxybenzothiazole

Annals of Neurology

Volumn 69, Issue 4, 2011, Pages 673-680

  Stankoff, Bruno ^a,b,c,d,e   Freeman, Leorah ^b,d,e   Aigrot, Marie Stéphane ^a,b,c   Chardain, Audrey ^b,d,e   Dollé, Frédéric ^e   Williams, Anna ^a,f   Galanaud, Damien ^b,d   Armand, Lucie ^a   Lehericy, Stéphane ^a,b,c,d   Lubetzki, Catherine ^a,b,c,d   Zalc, Bernard ^a,b,c,d   Bottlaender, Michel ^e  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c CNRS   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 ( 4' METHYLAMINOPHENYL) 6 HYDROXYBENZOTHIAZOLE; 2 ( 4' METHYLAMINOPHENYL) 6 HYDROXYBENZOTHIAZOLE C 11; AMYLOID; BENZOTHIAZOLE DERIVATIVE; BIOLOGICAL MARKER; FLUORESCENT DYE; MYELIN; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BABOON; BRAIN; BRAIN DAMAGE; CADAVER; CASE REPORT; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEMYELINATING DISEASE; FEMALE; FLUORESCENCE; HUMAN; IMAGE ANALYSIS; INJECTION; ISOTOPE LABELING; MALE; MOUSE; MULTIPLE SCLEROSIS; MUTANT; MYELINATION; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REMYELINIZATION; TISSUE SECTION;

ANIMALS; BENZOTHIAZOLES; BRAIN; CADAVER; CARBON RADIOISOTOPES; DEMYELINATING DISEASES; HUMANS; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MULTIPLE SCLEROSIS; NERVE REGENERATION; PAPIO ANUBIS; POSITRON-EMISSION TOMOGRAPHY;

EID: 79955379054     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22320     Document Type: Article

References (36)

1. Patrikios P, Stadelmann C, Kutzelnigg A, et al. Remyelination is extensive in a subset of multiple sclerosis patients. Brain 2006; 129: 3165-3172. (Pubitemid 44871433)
2. Dubois-Dalcq M, Williams A, Stadelmann C, et al. From fish to man: understanding endogenous remyelination in central nervous system demyelinating diseases. Brain 2008; 131: 1686-1700. (Pubitemid 351957449)
3. Lubetzki C, Williams A, Stankoff B., Promoting repair in multiple sclerosis: problems and prospects. Curr Opin Neurol 2005; 18: 237-244. (Pubitemid 40813749)
4. Zawadzka M, Franklin RJ., Myelin regeneration in demyelinating disorders: new developments in biology and clinical pathology. Curr Opin Neurol 2007; 20: 294-298. (Pubitemid 46743111)
5. Barkhof F, Bruck W, De Groot CJ, et al. Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance. Arch Neurol 2003; 60: 1073-1081. (Pubitemid 36975794)
6. Chen JT, Collins DL, Atkins HL, et al. Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions. Ann Neurol 2008; 63: 254-262. (Pubitemid 351355304)
7. Chen JT, Collins DL, Freedman MS, et al. Local magnetization transfer ratio signal inhomogeneity is related to subsequent change in MTR in lesions and normal-appearing white-matter of multiple sclerosis patients. Neuroimage 2005; 25: 1272-1278. (Pubitemid 40591668)
8. Chen JT, Kuhlmann T, Jansen GH, et al. Voxel-based analysis of the evolution of magnetization transfer ratio to quantify remyelination and demyelination with histopathological validation in a multiple sclerosis lesion. Neuroimage 2007; 36: 1152-1158. (Pubitemid 47001724)
9. Dwyer M, Bergsland N, Hussein S, et al. A sensitive, noise-resistant method for identifying focal demyelination and remyelination in patients with multiple sclerosis via voxel-wise changes in magnetization transfer ratio. J Neurol Sci 2009; 282: 86-95.
10. Laule C, Leung E, Lis DK, et al. Myelin water imaging in multiple sclerosis: quantitative correlations with histopathology. Mult Scler 2006; 12: 747-753. (Pubitemid 46111766)
11. Song SK, Yoshino J, Le TQ, et al. Demyelination increases radial diffusivity in corpus callosum of mouse brain. Neuroimage 2005; 26: 132-140. (Pubitemid 40602893)
12. Vavasour IM, Laule C, Li DK, et al. Longitudinal changes in myelin water fraction in two MS patients with active disease. J Neurol Sci 2009; 276: 49-53.
13. Stankoff B, Wang Y, Bottlaender M, et al. Imaging of CNS myelin by positron-emission tomography. Proc Natl Acad Sci U S A 2006; 103: 9304-9309. (Pubitemid 43902573)
14. Wang Y, Wu C, Caprariello AV, et al. In vivo quantification of myelin changes in the vertebrate nervous system. J Neurosci 2009; 29: 14663-14669.
15. Wu C, Tian D, Feng Y, et al. A novel fluorescent probe that is brain permeable and selectively binds to myelin. J Histochem Cytochem 2006; 54: 997-1004. (Pubitemid 44298586)
16. Xiang Z, Nesterov EE, Skoch J, et al. Detection of myelination using a novel histological probe. J Histochem Cytochem 2005; 53: 1511-1516. (Pubitemid 41720690)
17. Klunk WE, Pettegrew JW, Abraham DJ., Quantitative evaluation of Congo red binding to amyloid-like proteins with a beta-pleated sheet conformation. J Histochem Cytochem 1989; 37: 1273-1281. (Pubitemid 19186029)
18. Ridsdale RA, Beniac DR, Tompkins TA, et al. Three-dimensional structure of myelin basic protein. II. Molecular modeling and considerations of predicted structures in multiple sclerosis. J Biol Chem 1997; 272: 4269-4275. (Pubitemid 27078497)
19. Klunk WE, Wang Y, Huang GF, et al. Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain. Life Sci 2001; 69: 1471-1484. (Pubitemid 32786721)
20. Wilson AA, Garcia A, Chestakova A, et al. A rapid one-step radiosynthesis of the beta-amyloid imaging radiotracer N-methyl-[11C]2-(4-methylaminophenyl)- 6-hydroxybenzothiazole ([11C]-6-OH-BTA-1). J Labelled Comp Radiopharm 2004; 47: 679-682. (Pubitemid 39390042)
21. Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B. Ann Neurol 2004; 55: 306-319. (Pubitemid 38269583)
22. Coman I, Aigrot MS, Seilhean D, et al. Nodal, paranodal and juxtaparanodal axonal proteins during demyelination and remyelination in multiple sclerosis. Brain 2006; 129: 3186-3195. (Pubitemid 44871435)
23. Williams A, Piaton G, Aigrot MS, et al. Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis ? Brain 2007; 130: 2554-2565. (Pubitemid 47511713)
24. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald criteria." Ann Neurol 2005; 58: 840-846. (Pubitemid 41746873)
25. Filippi M, Rocca MA, Horsfield MA, et al. Increased spatial resolution using a three-dimensional T1-weighted gradient-echo MR sequence results in greater hypointense lesion volumes in multiple sclerosis. AJNR Am J Neuroradiol 1998; 19: 235-238. (Pubitemid 30413784)
26. Filippi M, Yousry T, Horsfield MA, et al. A high-resolution three-dimensional T1-weighted gradient echo sequence improves the detection of disease activity in multiple sclerosis. Ann Neurol 1996; 40: 901-907. (Pubitemid 27044608)
27. Moraal B, Wattjes MP, Geurts JJ, et al. Improved detection of active multiple sclerosis lesions: 3D subtraction imaging. Radiology 2010; 255: 154-163.
28. Readhead C, Popko B, Takahashi N, et al. Expression of a myelin basic protein gene in transgenic shiverer mice: correction of the dysmyelinating phenotype. Cell 1987; 48: 703-712. (Pubitemid 18096947)
29. Kurtzke JF., Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452. (Pubitemid 14237132)
30. Nelson F, Poonawalla A, Hou P, et al. 3D MPRAGE improves classification of cortical lesions in multiple sclerosis. Mult Scler 2008; 14: 1214-1219.
31. Vourc'h P, Andres C., Oligodendrocyte myelin glycoprotein (OMgp): evolution, structure and function. Brain Res 2004; 45: 115-124. (Pubitemid 38656110)
32. Luo X, Sharma D, Inouye H, et al. Cytoplasmic domain of human myelin protein zero likely folded as beta-structure in compact myelin. Biophysical J 2007; 92: 1585-1597. (Pubitemid 46393469)
33. Klunk WE, Lopresti BJ, Ikonomovic MD, et al. Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain. J Neurosci 2005; 25: 10598-10606. (Pubitemid 41681907)
34. Klunk WE, Wang Y, Huang GF, et al. The binding of 2-(4-methylaminophenyl) benzothiazole to postmortem brain homogenates is dominated by the amyloid component. J Neurosci 2003; 23: 2086-2092. (Pubitemid 36368896)
35. Fodero-Tavoletti MT, Rowe CC, McLean CA, et al. Characterization of PiB binding to white matter in Alzheimer disease and other dementias. J Nucl Med 2009; 50: 198-204.
36. Moll NM, Cossoy MB, Fisher E, et al. Imaging correlates of leukocyte accumulation and CXCR4/CXCL12 in multiple sclerosis. Arch Neurol 2009; 66: 44-53.